Clinical Trials Browser

Phase 1 × Metastatic Castration-Resistant Prostate Cancer × Methylprednisolone × Clear all

NCT04666129 2025-08-17

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Metastatic Castration-Resistant Prostate Cancer